Another explanation could possibly be development of central hypothalamic ghrelin resistance, which causes a disproportionate increase in ghrelin levels in several catabolic states, such as cachexia in oncologic populations in human and animals studies [44,45]. The gene discussed is GHRL; the disease is Cachexia.